Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004
<p>Abstract</p> <p>Background</p> <p>Using non-steroidal anti-inflammatory drugs (NSAIDs) as a case, we used Taiwan's National Health Insurance (NHI) database, to empirically explore the association between policy interventions (price regulation, new drug entry, an...
Saved in:
Main Authors: | Tsai Yi-Wen (Author), Hsiao Fei-Yuan (Author), Huang Weng-Foung (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
by: Hsiao Fei-Yuan, et al.
Published: (2007) -
A Nationwide Survey of Risk Factors for Stillbirth in Taiwan, 2001-2004
by: I-Jan Hu, et al.
Published: (2012) -
Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of Thiazolidinediones for diabetes
by: Tsai Chia-Rung, et al.
Published: (2011) -
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
by: Evelien Moorkens, et al.
Published: (2021) -
The impact of external reference pricing on pharmaceutical costs and market dynamics
by: Dominic Voehler, et al.
Published: (2023)